• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Potentially Inappropriate Prescribing in Hospitalized Older Adult High-Cost Health Care Users: A Pilot Study.住院高成本医疗保健使用者中潜在不适当用药情况:一项试点研究。
Can J Hosp Pharm. 2022 Jul 4;75(3):219-224. doi: 10.4212/cjhp.3122. eCollection 2022 Summer.
2
Prevalence of potentially inappropriate prescribing and prescribing omissions in older Irish adults: findings from The Irish LongituDinal Study on Ageing study (TILDA).爱尔兰老年人群中潜在不适当处方和处方遗漏的患病率:爱尔兰纵向老龄化研究(TILDA)的结果
Eur J Clin Pharmacol. 2014 May;70(5):599-606. doi: 10.1007/s00228-014-1651-8. Epub 2014 Feb 4.
3
Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact.STOPP/START 标准的应用:老年人潜在不适当处方的流行率的系统评价,以及临床、人文和经济影响的证据。
J Clin Pharm Ther. 2013 Oct;38(5):360-72. doi: 10.1111/jcpt.12059. Epub 2013 Apr 2.
4
Evaluating Inappropriate Medication Prescribing Among Elderly Patients in Palestine Using the STOPP/ START Criteria.采用 STOPP/START 标准评估巴勒斯坦老年患者中的不适当用药情况。
Clin Interv Aging. 2022 Sep 27;17:1433-1444. doi: 10.2147/CIA.S382221. eCollection 2022.
5
Potentially inappropriate prescribing to older patients in primary care in the Netherlands: a retrospective longitudinal study.荷兰初级医疗中对老年患者潜在不适当的处方开具情况:一项回顾性纵向研究
Age Ageing. 2017 Jul 1;46(4):614-619. doi: 10.1093/ageing/afw243.
6
Evaluating the prevalence of potentially inappropriate prescribing in older adults in intermediate care facilities: a cross-sectional observational study.评估中级护理机构中老年人潜在不适当处方的流行情况:一项横断面观察性研究。
Int J Clin Pharm. 2017 Jun;39(3):527-535. doi: 10.1007/s11096-017-0452-4. Epub 2017 Mar 17.
7
Potentially Inappropriate Prescribing and Potential Prescribing Omissions and Their Association with Adverse Drug Reaction-Related Hospital Admissions.潜在不适当处方、潜在处方遗漏及其与药物不良反应相关住院的关联。
J Clin Med. 2024 Jan 6;13(2):323. doi: 10.3390/jcm13020323.
8
A prevalence study of potentially inappropriate prescribing in Irish long-term care residents.爱尔兰长期护理居民潜在不适当处方的流行研究。
Drugs Aging. 2013 Jan;30(1):39-49. doi: 10.1007/s40266-012-0039-7.
9
The Association Between Potentially Inappropriate Prescribing and Medication-Related Hospital Admissions in Older Patients: A Nested Case Control Study.老年患者潜在不适当处方与药物相关住院之间的关联:一项巢式病例对照研究。
Drug Saf. 2016 Jan;39(1):79-87. doi: 10.1007/s40264-015-0361-1.
10
Does potentially inappropriate prescribing predict an increased risk of admission to hospital and mortality? A longitudinal study of the 'oldest old'.潜在不适当处方是否预示着住院和死亡风险增加?对“最年长老人”的纵向研究。
BMC Geriatr. 2020 Jan 28;20(1):28. doi: 10.1186/s12877-020-1432-4.

引用本文的文献

1
Improving medication prescribing-related outcomes for vulnerable elderly in transitions on high-risk medications (IMPROVE-IT HRM): a pilot randomized trial protocol.改善高危药物转换期弱势老年人的药物处方相关结局(IMPROVE-IT HRM):一项试点随机试验方案
Pilot Feasibility Stud. 2024 Apr 10;10(1):60. doi: 10.1186/s40814-024-01484-6.
2
[Not Available].[不可用]。
Can J Hosp Pharm. 2022 Jul 4;75(3):157-158. doi: 10.4212/cjhp.3327. eCollection 2022 Summer.
3
Resolving Medication Reconciliation.解决用药核对问题。
Can J Hosp Pharm. 2022 Jul 4;75(3):155-156. doi: 10.4212/cjhp.3324. eCollection 2022 Summer.

本文引用的文献

1
Medication use and its impact on high-cost health care users among older adults: protocol for the population-based matched cohort HiCOSTT study.老年人中药物使用及其对高成本医疗保健使用者的影响:基于人群匹配队列 HiCOSTT 研究的方案。
CMAJ Open. 2021 Jan 11;9(1):E44-E52. doi: 10.9778/cmajo.20190196. Print 2021 Jan-Mar.
2
Potentially Inappropriate Prescribing Among Older Persons: A Meta-Analysis of Observational Studies.老年人潜在不适当处方:观察性研究的荟萃分析。
Ann Fam Med. 2019 May;17(3):257-266. doi: 10.1370/afm.2373.
3
The Burden of Opioid-Related Mortality in the United States.美国阿片类药物相关死亡率负担。
JAMA Netw Open. 2018 Jun 1;1(2):e180217. doi: 10.1001/jamanetworkopen.2018.0217.
4
Systematic review of high-cost patients' characteristics and healthcare utilisation.高成本患者特征及医疗保健利用的系统评价
BMJ Open. 2018 Sep 8;8(9):e023113. doi: 10.1136/bmjopen-2018-023113.
5
Measuring the Burden of Opioid-related Mortality in Ontario, Canada.衡量加拿大安大略省阿片类药物相关死亡率的负担
J Addict Med. 2018 Sep/Oct;12(5):418-419. doi: 10.1097/ADM.0000000000000412.
6
Managing High-Cost Healthcare Users: The International Search for Effective Evidence-Supported Strategies.管理高费用医疗保健用户:国际上寻找有效证据支持策略。
J Am Geriatr Soc. 2018 May;66(5):1002-1008. doi: 10.1111/jgs.15257. Epub 2018 Feb 10.
7
Effect of an In-Hospital Multifaceted Clinical Pharmacist Intervention on the Risk of Readmission: A Randomized Clinical Trial.医院多方面临床药师干预对再入院风险的影响:一项随机临床试验。
JAMA Intern Med. 2018 Mar 1;178(3):375-382. doi: 10.1001/jamainternmed.2017.8274.
8
Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis.老年人因药物不良反应导致的住院情况:一项荟萃分析。
Eur J Clin Pharmacol. 2017 Jun;73(6):759-770. doi: 10.1007/s00228-017-2225-3. Epub 2017 Mar 1.
9
Missed Opportunity to Deprescribe: Docusate for Constipation in Medical Inpatients.停用药物的错失良机:住院患者便秘使用多库酯钠的情况
Am J Med. 2016 Sep;129(9):1001.e1-7. doi: 10.1016/j.amjmed.2016.04.008. Epub 2016 May 3.
10
STOPP/START criteria for potentially inappropriate prescribing in older people: version 2.老年人潜在不适当处方的STOPP/START标准:第2版
Age Ageing. 2015 Mar;44(2):213-8. doi: 10.1093/ageing/afu145. Epub 2014 Oct 16.

住院高成本医疗保健使用者中潜在不适当用药情况:一项试点研究。

Potentially Inappropriate Prescribing in Hospitalized Older Adult High-Cost Health Care Users: A Pilot Study.

作者信息

Sanh Monica, Holbrook Anne, Macdonald Peter D M, Lee Justin

机构信息

, PharmD, ACPR, is a Clinical Pharmacist with the University Health Network, Toronto, Ontario.

, MD, PharmD, MSc, FRCPC, is a Clinical Pharmacologist and Internal Medicine Specialist with St Joseph's Healthcare Hamilton, and a Professor in the Department of Medicine and Director of the Division of Clinical Pharmacology and Toxicology, McMaster University, Hamilton, Ontario.

出版信息

Can J Hosp Pharm. 2022 Jul 4;75(3):219-224. doi: 10.4212/cjhp.3122. eCollection 2022 Summer.

DOI:10.4212/cjhp.3122
PMID:35847459
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9245409/
Abstract

BACKGROUND

High-cost health care users use disproportionate amounts of health care resources relative to the typical patient. It is unclear to what extent poor-quality prescribing, including potentially inappropriate prescribing (PIP), may be contributing to their adverse outcomes and health utilization costs.

OBJECTIVES

To evaluate the prevalence of PIP and to explore its impact in older adult high-cost health care users.

METHODS

The charts of older adult high-cost health care users admitted to 2 academic hospitals in Ontario, Canada, in fiscal year 2015/16 were reviewed. Eligible patients were at least 66 years old with at least 5 emergency department visits and 3 hospital admissions in the previous year. A total of 243 patients met these criteria, of whom 100 were randomly selected for review. Cases of PIP were identified using explicit prescribing quality indicators, including the STOPP/START criteria. Types of PIP included potentially inappropriate medications (PIMs) and potential prescribing omissions (PPOs). Log-linear regression was used to characterize the relationship between PIP and future health care utilization. Medications were reconciled to determine the proportion of PIP addressed by the time of discharge.

RESULTS

Eighty-nine of the 100 patients had at least 1 instance of PIP. In total, 276 PIMs and 54 PPOs were identified. Of the 271 instances of PIP identified on admission, only 38 (14%) were resolved by the time of hospital discharge. Each additional PPO was associated with a 1.43-fold increase in the rate of future emergency department visits ( < 0.001).

CONCLUSIONS

The rate of PIP among older adult high-cost health care users was high. Despite frequent interactions with the health care system, many opportunities to improve the quality of prescribing for this vulnerable population were missed. Greater attention to medication optimization is needed.

摘要

背景

与普通患者相比,高成本医疗使用者消耗了不成比例的医疗资源。目前尚不清楚包括潜在不适当处方(PIP)在内的低质量处方在多大程度上可能导致了他们的不良后果和医疗使用成本。

目的

评估潜在不适当处方的患病率,并探讨其对老年高成本医疗使用者的影响。

方法

回顾了2015/16财政年度加拿大安大略省两家学术医院收治的老年高成本医疗使用者的病历。符合条件的患者年龄至少66岁,前一年至少有5次急诊就诊和3次住院。共有243名患者符合这些标准,其中100名被随机选择进行审查。使用明确的处方质量指标(包括STOPP/START标准)识别潜在不适当处方的病例。潜在不适当处方的类型包括潜在不适当药物(PIMs)和潜在处方遗漏(PPOs)。使用对数线性回归来描述潜在不适当处方与未来医疗使用之间的关系。核对药物以确定出院时解决的潜在不适当处方的比例。

结果

100名患者中有89名至少有1例潜在不适当处方。总共识别出276种潜在不适当药物和54种潜在处方遗漏。在入院时识别出的271例潜在不适当处方中,到出院时只有38例(14%)得到解决。每增加一例潜在处方遗漏,未来急诊就诊率就会增加1.43倍(P<0.001)。

结论

老年高成本医疗使用者中潜在不适当处方的发生率很高。尽管与医疗系统有频繁互动,但改善这一弱势群体处方质量的许多机会都被错过了。需要更加关注药物优化。